To evaulate the possible pathogenetic significance of allergen-specific IgA antibody in respiratory secretion from asthmatics, we measured house dust mite(HDM)-specific IgA antibody in 3% saline-induced sputum from 23 HDM-sensitive asthmatics, 4atopic asthmatics without mite-sensitivity, 6 non-atopic asthmatics, and 13 nonatoplc, non-asthmatic controls (including 6 non-atopic healthy controls, 4 patients with chronic bronchitis, and 3 patients with rheumatoid arthritis) by ELISA. We also measured HDM-specific IgA antibody in serum and numbers of eosinophils in sputum.
1) Levels of HDM-specific IgA antibody In sputum from mite-sensitive asthmatics
were significantly higher than those from non-atopic, non-asthmatic controls and
non-atopic asthmatics(p<0.05). Levels of HDM-specific IgA antibody in sputum from
atopic asthmatics without mitesensitivity were significantly higher than those from
was not significantly different between two groups (p>0.05).
2) The ratio of HDM-specific IgA antibody to albumin in sputum was not significantly different in mite-sensitive asthmatics with sputum eosulophila (≥5% of 200 counted leukocytes) and those without sputum eosinophilia(p>0.05).
3) The ratio of HDM-specific IgA to albumin in sputum from asthmatics was higher
than that of serum.
4) There was no significant correlation of HDM- specific IgA/albumin ratios between
serum and sputum (p>0.05).
5) When comparing sputum and saliva samples from 7 mite-sensitive asthmatics,
levels of HDM-specific IgA antibody in sputum were significantly higher than those in saliva (p<0.05).
In conclusion, HDM-specific IgA anti-body was increased in sputum from HDM-sensitive asthmatics, and it might be locally produced from bronchial mucosa. To evaluate the pathogenetic significance of allergen-specific IgA antibody in respiratory
secretion from asthmatics, further studies might be needed.